Klaus Veitinger

Klaus Veitinger

Presidente presso TRICIDA, INC.

Patrimonio netto: - $ in data 30/04/2024

62 anni
Health Technology
Consumer Services
Distribution Services

Provenienza dei contatti di primo grado di Klaus Veitinger

EntitàTipo di entitàSettore Industriale
99
Subsidiary Investment Managers 99
Subsidiary Pharmaceuticals: Major 32
Public Company Pharmaceuticals: Major 27
Public Company Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 19
11
Holding Company Pharmaceuticals: Major 11
9
Subsidiary Pharmaceuticals: Major 9
6
Holding Company Biotechnology 6
6
Holding Company Pharmaceuticals: Major 6
3
Subsidiary Pharmaceuticals: Major 3
3
Private Company Biotechnology 3

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Klaus Veitinger tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Investment Managers

Sam Isaly

Sven Borho

Carl Gordon

Geoffrey Hsu

Joshua Golomb

Carter Neild

Trevor M. Polischuk

Topher Orr

Matthew Rizzo

Andrew P. Kanarek

Scotland Stevens

Chief Executive Officer

Founder

Founder

Portfolio Manager-Equities

Analyst-Equity

Private Equity Investor

Portfolio Manager-Equities

Analyst-Equity

Portfolio Manager-Fixed Income

Trading-Equity

Portfolio Manager-Equities

AMGEN INC. Pharmaceuticals: Major

Leonard Schaeffer

Helen Torley

J. Garland

Kathryn Falberg

Kevin Koch

Glenn Sblendorio

John Butler

Director/Board Member

Corporate Officer/Principal

Sales & Marketing

Director of Finance/CFO

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Stanford University College/University

Srini Akkaraju Akkaraju

Dan Spiegelman

Robert Jacks

William Quinn

Diyong Xu

Doctorate Degree

Undergraduate Degree

Graduate Degree

Graduate Degree

Graduate Degree

Biotechnology

Srini Akkaraju Akkaraju

J. Garland

Dan Spiegelman

John Orwin

Kenneth Hillan

Corporate Officer/Principal

Corporate Officer/Principal

Treasurer

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Robert Jacks

Matthew Rizzo

Mark Vignola

Aaron Royston

Mark R Jelley

Undergraduate Degree

Masters Business Admin

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Harvard College College/University

Carl Gordon

Rishi Gupta

Keith Gottesdiener

Kipyegon Kitur

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Keith Gottesdiener

Tal Zaks

Aaron Royston

Roy Amariglio

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Masters Business Admin

Biotechnology

Scott Rocklage

Gerrit Klaerner

Jerry M. Buysse

Edward Hejlek

Chairman

Founder

Corporate Officer/Principal

General Counsel

Harvard Business School College/University

Lorenzo M. Tallarigo

Geoffrey Hsu

Lars Enstrom

Doctorate Degree

Masters Business Admin

Masters Business Admin

SEAGEN INC. Pharmaceuticals: Major

Srini Akkaraju Akkaraju

Daniel Welch

John Orwin

Director/Board Member

Director/Board Member

Director/Board Member

The Trustees of Columbia University in The City of New York College/University

Joshua Golomb

David Bonita

Keith Gottesdiener

Undergraduate Degree

Doctorate Degree

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Scott Rocklage

Carl Gordon

Vivek Sivathanu

Doctorate Degree

Doctorate Degree

Doctorate Degree

Financial Conglomerates

Sam Isaly

Sven Borho

Geoffrey Hsu

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Barbara Duncan

Jack Khattar

Scotland Stevens

Masters Business Admin

Masters Business Admin

Masters Business Admin

Biotechnology

Glenn Sblendorio

Paul Hastings

John Butler

Director of Finance/CFO

Corporate Officer/Principal

Sales & Marketing

ELI LILLY AND COMPANY Pharmaceuticals: Major

Gino Santini

Lorenzo M. Tallarigo

Sara Bonstein

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

John Orwin

Minnie Baylor-Henry

Brendan Weber

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

TERNS PHARMACEUTICALS, INC. Biotechnology

Carl Gordon

Mark Vignola

Bryan Yoon

Director/Board Member

Director of Finance/CFO

Chief Operating Officer

HALOZYME THERAPEUTICS, INC. Biotechnology

Barbara Duncan

Helen Torley

Kathryn Falberg

Director/Board Member

Chief Executive Officer

Chairman

Investment Managers

Srini Akkaraju Akkaraju

Dan Spiegelman

Keith Gottesdiener

Founder

Private Equity Investor

Private Equity Investor

Miscellaneous Commercial Services

Helen Torley

Paul Hastings

John Orwin

Director/Board Member

Chairman

Director/Board Member

Pharmaceuticals: Major

Kathryn Falberg

William Quinn

Robert McKague

Director of Finance/CFO

Corporate Officer/Principal

Compliance Officer

CARGO THERAPEUTICS, INC. Biotechnology

Srini Akkaraju Akkaraju

John Orwin

Director/Board Member

Chairman

Medical Distributors

Sandipkumar S. Kapadia

Rocco Venezia

Director/Board Member

Director/Board Member

Medical Specialties

Paul Hastings

John Butler

Corporate Officer/Principal

Corporate Officer/Principal

Pace University College/University

Glenn Sblendorio

Corey Schrader

Undergraduate Degree

Undergraduate Degree

College/University

Geoffrey Hsu

David Bonita

Undergraduate Degree

Undergraduate Degree

FORTRESS INVESTMENT GROUP LLC Investment Managers

Matthew Rizzo

Michael Eggenberg

Corporate Officer/Principal

Chief Executive Officer

THE MEDICINES COMPANY Pharmaceuticals: Major

Glenn Sblendorio

John Mohr

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Daniel Bradbury

Jonathan Silverstein

Director/Board Member

Director/Board Member

HARMONY BIOSCIENCES HOLDINGS, INC. Pharmaceuticals: Major

Aaron Royston

Sandipkumar S. Kapadia

Director/Board Member

Director of Finance/CFO

MINERALYS THERAPEUTICS, INC. Biotechnology

Srini Akkaraju Akkaraju

Glenn Sblendorio

Director/Board Member

Director/Board Member

AMAG PHARMACEUTICALS, INC. Pharmaceuticals: Major

Gino Santini

John Tucker

Chairman

Corporate Officer/Principal

Biotechnology

Jonathan Silverstein

Keith Gottesdiener

Director/Board Member

Chief Executive Officer

Biotechnology

Gino Santini

Sara Bonstein

Director/Board Member

Corporate Officer/Principal

IKARIA, INC. Biotechnology

Matthew Rizzo

Rocco Venezia

Corporate Officer/Principal

Corporate Officer/Principal

XTANT MEDICAL HOLDINGS, INC. Medical Specialties

Matthew Rizzo

Michael Eggenberg

Director/Board Member

Director/Board Member

THE BIOTECH GROWTH TRUST PLC Investment Trusts/Mutual Funds

Sven Borho

Geoffrey Hsu

Director/Board Member

Director/Board Member

GELESIS INC Biotechnology

Jonathan Silverstein

Rishi Gupta

Chairman

Director/Board Member

Pharmaceuticals: Major

John Orwin

Keith Gottesdiener

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Carl Gordon

Jonathan Silverstein

Director/Board Member

Director/Board Member

ORIC PHARMACEUTICALS, INC. Pharmaceuticals: Major

Carl Gordon

Rishi Gupta

Director/Board Member

Director/Board Member

AFFYMAX, INC. Biotechnology

Dan Spiegelman

John Orwin

Director/Board Member

Chief Executive Officer

Rutgers State University of New Jersey College/University

John Orwin

Sandipkumar S. Kapadia

Undergraduate Degree

Masters Business Admin

PASSAGE BIO, INC. Biotechnology

Carl Gordon

Sandipkumar S. Kapadia

Director/Board Member

Director/Board Member

The College of New Jersey College/University

Brendan Weber

Sara Bonstein

Undergraduate Degree

Undergraduate Degree

PACIRA BIOSCIENCES, INC. Pharmaceuticals: Major

Carl Gordon

Paul Hastings

Director/Board Member

Chairman

Statistiche

Distribuzione geografica

Stati Uniti 48
Regno Unito 3
Francia 2

Settori

Health Technology 31
Consumer Services 12
Finance 7
Commercial Services 2
Distribution Services 2

Posizioni

Director/Board Member 585
Independent Dir/Board Member 201
Corporate Officer/Principal 174
Chairman 106
Undergraduate Degree 85
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA